CLINICAL_TRIALS
trial_result
· 2018-12-05
Clinical Trial Update: Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid Arthritis [Phase 3]
Summary
Phase 3 trial update assessing long-term safety and efficacy of BI 695501 in rheumatoid arthritis completed with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Arthritis, Rheumatoid | Phase 3 | Status: COMPLETED | Results posted: 2018-12-05